Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IGC Pharma, Inc. | 1,134,252 | reported | 17 Oct 2025 | tx 45+5,747,500−2,188,521 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Oct 2025 | GIFT | IGC Pharma, Inc. | 50,000 | 0.00 USD | |
| 17 Oct 2025 | GRANT_AWARD | IGC Pharma, Inc. | 500,000 | 0.00 USD | deriv |
| 17 Oct 2025 | GRANT_AWARD | IGC Pharma, Inc. | 1,000,000 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 58,333 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 58,333 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 83,333 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 95,000 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 58,333 | 0.00 USD | |
| 13 Mar 2024 | GRANT_AWARD | IGC Pharma, Inc. | 550,000 | 0.00 USD | deriv |
| 13 Mar 2024 | GRANT_AWARD | IGC Pharma, Inc. | 360,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 95,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 58,334 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 83,333 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 83,333 | 0.00 USD | |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 58,334 | 0.00 USD | |
| 20 Jun 2023 | GRANT_AWARD | IGC Pharma, Inc. | 380,000 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 83,333 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 58,334 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | IGC Pharma, Inc. | 175,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | IGC Pharma, Inc. | 300,000 | 0.00 USD | deriv |
| 31 May 2022 | EXERCISE | IGC Pharma, Inc. | 28,125 | 0.00 USD |